Start your intake Temperature Control and Storage Requirements for Compounded Semaglutide Compounded semaglutide must be kept refrigerated at 28C (3646F) before use
MMS was a Lundbeck postdoctoral fellow
FDA approves Novo Nordisks oral semaglutide (Rybelsus) for CV risk reduction in T2DM adults owenhaskins Oct 20, 2025 3 min read Novo Nordisk has received FDA approval for Rybelsus for reducing the risk of major adverse cardiovascular events (MACE) such as cardiovascular (CV) death, heart attack, or stroke in adults with type 2 diabetes who are at high risk for these events, whether they've had a prior CV event or not (primary and secondary prevention)
[DOI] [PMC free article] [PubMed] [Google Scholar] 24.Massri N., Loia R., Sones J.L., Arora R., Douglas N.C
The STEP 1 trial (semaglutide 2.4 mg, adults with obesity or overweight plus a weight-related condition) reported average weight loss of about 14.9 percent of baseline body weight at 68 weeks versus 2.4 percent with placebo (Wilding JPH, et al
